|
|
| On-Demand Webinar: Expanding CAR T Beyond Oncology | CAR T therapies, known for bringing groundbreaking treatment advancements to oncology, are beginning to show promise in additional therapeutic areas. Watch our on-demand webinar to explore how collaboration between therapeutically aligned teams impacts study delivery for CAR T in autoimmune disease and neurology clinics. |
|
|
FOCUS ON REGULATORY & COMPLIANCE |
|
|
|
By Jackie Mulryne, Eftychia Sideri, and Heba Jalil, Arnold & Porter | It will be the first country to introduce a tailored framework for innovative medicine manufacturers at or close to where patients receive care. |
|
|
|
This segment features a discussion around the obstacles to establishing a standardized production pipeline for mRNA therapeutics across the industry, as well as some of the approaches being considered to standardize cold chain management protocols for mRNA products. |
|
|
| The Problem With Construction Quality | White Paper | By Rich Tree, CAI | Data center construction quality management is inadequate, with issues traced to human error. A stronger focus on quality control and assurance is needed for success. |
|
|
| Ask The Expert: 21 CFR Part 11 Compliance | Webinar | BD Biosciences | Hear from a 21 CFR Part 11 expert supporting pharmaceutical, diagnostic, and medical device companies with implementing solutions and systems to ensure compliance. |
|
|
|
|
| Rare Endpoints: Delivering On Unmet Patient Needs | Podcast | By Jamie Pierson and Kim MacDonnell, Parexel International | Listen as speakers discuss the regulatory landscape's impact on accelerating rare disease therapies, highlighting the role of surrogate endpoints in achieving better treatments and patient outcomes. |
|
|
|
|
|
|
|
| Despite significant advances, challenges remain in optimizing AAV-based treatments for broader clinical application. Join Cell & Gene Live on December 10th for a discussion on the latest developments in AAV vector design, manufacturing processes, and clinical strategies as well as key issues such as immunogenicity and regulatory considerations that are shaping the future of AAV gene therapies. Registration is free thanks to the support of Roche CustomBiotech. |
|
|
REGULATORY & COMPLIANCE SOLUTIONS |
|
|
|
Connect With Cell & Gene: |
|
|
|